Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan

被引:0
|
作者
Tasaka, Yuichi [1 ,2 ]
Tanaka, Akihiro [1 ,2 ,5 ]
Yasunaga, Daiki [1 ,2 ]
Asakawa, Takashige [2 ,3 ]
Araki, Hiroaki [4 ]
Tanaka, Mamoru [1 ,2 ]
机构
[1] Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan
[2] Ehime Soc Hosp Pharmacists, 454 Shitsukawa, Toon, Ehime 7910295, Japan
[3] Saiseikai Saijo Hosp, Dept Pharm, 269-1 Tsuitachi, Saijo, Ehime 7930027, Japan
[4] Shujitsu Univ, Sch Pharm, Naka Ku, 1-6-1 Nishigawara, Okayama, Okayama 7038516, Japan
[5] Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan
关键词
Pharmaceutical intervention; Adverse drug reaction; Potential drug-related problem; Elderly patients; Renal dysfunction; Polypharmacy;
D O I
10.1186/s40780-018-0125-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundPharmaceutical intervention enables safe and effective pharmacotherapy by avoiding of adverse drug reactions (ADRs) and efficacy attenuations. Many prescriptions require optimization, and pharmaceutical interventions are inextricably associated with the prevention of potential drug-related problems (DRPs). Although the analysis and understanding of pharmaceutical interventions can lead to improvement in prescription, the analysis of routine pharmaceutical interventions in Japan in insufficient. Thus, we conducted this study to understand potential DRPs by analyzing routine pharmaceutical interventions made by pharmacists in Japan.MethodsPharmacists register the details of pharmaceutical interventions (excluding personal patient information) in a web-based database. We classified data of pharmaceutical interventions into 13 DRP types, 43 DRP subtypes, and 10 intervention categories (e.g., avoidance of serious ADRs and renal dosing recommendations). These data were analyzed with a focus on renal dysfunction and polypharmacy.ResultsDuring the study period, 2376 pharmaceutical interventions were performed. Overall, 68.2% of pharmaceutical interventions were for patients aged over 65years. The most frequently detected potential DRP was overdosage, followed by omission of prescription, contraindications, and duplication of a drug with similar effect. The main cause of contraindication and overdosage was renal function deterioration, and that of polypharmacy was duplication of a drug with similar effect. Using our original evidence-based approach, we found that 2376 pharmaceutical interventions prevented ADRs for 1678 drugs, with potential cost savings of up to USD 2,657,820.ConclusionsOur results indicate that the analysis of routine pharmaceutical interventions is beneficial for detecting potential DRPs. Our findings also show that, in an aging society, pharmacists have an important role in providing medication safety, with potential cost savings.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [41] Potential drug-related problems detected by electronic expert support system: physicians' views on clinical relevance
    Hammar, Tora
    Lidstrom, Bodil
    Petersson, Goran
    Gustafson, Yngve
    Eiermann, Birgit
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 941 - 948
  • [42] Potential drug-related problems detected by electronic expert support system: physicians’ views on clinical relevance
    Tora Hammar
    Bodil Lidström
    Göran Petersson
    Yngve Gustafson
    Birgit Eiermann
    International Journal of Clinical Pharmacy, 2015, 37 : 941 - 948
  • [43] Drug-Related Problems Detected in Complex Chronic Patients by Community Pharmacists of Catalonia: Perception of the Person-Centred Approach Necessity
    Torres-Novellas, Berta
    Rius, Pilar
    Figueiredo-Escriba, Carlos
    Marino, Eduardo L.
    Modamio, Pilar
    HEALTHCARE, 2024, 12 (02)
  • [44] The analysis of drug-related problems identified by the Polish community pharmacists participating in Pharmaceutical Care in Arterial Hypertension and Diabetes (PCAHD) Project
    Skowron, Agnieszka
    Polak, Wioletta
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (04) : 857 - 857
  • [45] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Xavier Pourrat
    Clarisse Roux
    Brigitte Bouzige
    Valérie Garnier
    Armelle Develay
    Benoit Allenet
    Martial Fraysse
    Jean-Michel Halimi
    Jacqueline Grassin
    Bruno Giraudeau
    Trials, 15
  • [46] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Allenet, Benoit
    Fraysse, Martial
    Halimi, Jean-Michel
    Grassin, Jacqueline
    Giraudeau, Bruno
    TRIALS, 2014, 15
  • [47] Drug-related problems identified by clinical pharmacists in nephrology department of a tertiary hospital in China-a single center study
    Liu, Xing-Xing
    Wang, Hui-Xia
    Hu, Yun-Yun
    Zhu, Xu-Ting
    Tan, Xin
    Yang, Yang
    Hang, Yong-Fu
    Zhu, Jian-Guo
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (08) : 8701 - 8708
  • [48] Pharmacotherapeutic follow-up of patients with Chagas disease using in use of benznidazole: drug-related problems and pharmaceutical interventions
    Ramalho Correia, Joao Paulo
    da Costa, Alanna Carla
    Rocha, Eduardo Arrais
    Pinto Quidute, Ana Rosa
    Candido, Darlan da Silva
    de Souza Ponciano, Angela Maria
    de Franca Fonteles, Marta Maria
    Oliveira, Maria de Fatima
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2017, 50 (03) : 334 - 340
  • [49] Screening Tools Used by Clinical Pharmacists to Identify Elderly Patients at Risk of Drug-Related Problems on Hospital Admission: A Systematic Review
    Brady, Amanda
    Curtis, Chris E.
    Jalal, Zahraa
    PHARMACY, 2020, 8 (02)
  • [50] The role of pharmacists' interventions in improving drug-related problems, blood pressure, and quality of life of patients with stage 5 chronic kidney disease
    Peri
    Nasution, Azizah
    Nasution, Alwi Thamrin
    PHARMACIA, 2022, 69 (01) : 175 - 180